» Articles » PMID: 17636461

Inhibition of Nitric Oxide-induced Apoptosis by Nicotine in Oral Epithelial Cells

Overview
Publisher Springer
Specialty Biochemistry
Date 2007 Jul 20
PMID 17636461
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Development of oral cancer is clearly linked to the usage of smokeless tobacco. The molecular mechanisms involved in this process are however not well understood. Toward this goal, we investigated the effect of smokeless tobacco exposure on apoptosis of oral epithelial cells. Exposure of oral epithelial cells to smokeless tobacco extract (STE) induces apoptosis in a dose-dependent manner, until a threshold level of nicotine is achieved upon which apoptosis is inhibited. 1 mM of nicotine is able to inhibit apoptosis significantly induced by STE in these oral cells. Exposure of cells to nicotine alone has no effect on apoptosis, but nicotine inhibits apoptosis induced by other agents present in STE. In this study we show that, the anti-apoptotic action of nicotine is specifically associated with down-regulation of nitric oxide (NO) production. Using specific inducers of NO, we have demonstrated that inhibition of apoptosis by nicotine is through down-regulation of NO production. Further, we observed that nicotine clearly acts as a sink of NO radicals, shown using peroxynitrite generator (SIN-1) in conjunction or absence of radical scavengers. Nicotine thus causes most damage in transformed epithelial cells as depicted by accumulation of nitrotyrosine in a 3-NT ELISA assay. Inhibition of apoptosis is a hallmark in tumor progression and propels development of cancer. It may further result in functional loss of apoptotic effector mechanisms in the transformed cells. Thus, our data clearly indicates that inhibition of NO-induced apoptosis by nicotine may lead to tobacco-induced oral carcinogenesis, and implies careful development of modalities in tobacco cessation programs.

Citing Articles

Smokeless tobacco extract inhibits proliferation and promotes apoptosis in oral mucous fibroblasts.

Li L, Zhou X, Wang Y Oncol Lett. 2018; 16(4):5066-5074.

PMID: 30250574 PMC: 6144942. DOI: 10.3892/ol.2018.9252.


Nicotine induces upregulated expression of beta defensin-2 via the p38MAPK pathway in the HaCaT human keratinocyte cell line.

Nakamura S, Saitoh M, Yamazaki M, Nishimura M, Kurashige Y, Arakawa T Med Mol Morphol. 2011; 43(4):204-10.

PMID: 21267696 DOI: 10.1007/s00795-010-0493-4.


Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Johnson M, Schilz J, Djordjevic M, Rice J, Shields P Cancer Epidemiol Biomarkers Prev. 2009; 18(12):3263-304.

PMID: 19959677 PMC: 2789344. DOI: 10.1158/1055-9965.EPI-09-0965.


FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.

Gemenetzidis E, Bose A, Riaz A, Chaplin T, Young B, Ali M PLoS One. 2009; 4(3):e4849.

PMID: 19287496 PMC: 2654098. DOI: 10.1371/journal.pone.0004849.

References
1.
Mei J, Hord N, Winterstein D, Donald S, Phang J . Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells. FASEB J. 2000; 14(9):1188-201. DOI: 10.1096/fasebj.14.9.1188. View

2.
Hoffmann D, Adams J, Lisk D, Fisenne I, Brunnemann K . Toxic and carcinogenic agents in dry and moist snuff. J Natl Cancer Inst. 1987; 79(6):1281-6. View

3.
Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y . Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 1996; 27(3 Pt 2):823-6. DOI: 10.1161/01.hyp.27.3.823. View

4.
Xie K, Fidler I . Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev. 1998; 17(1):55-75. DOI: 10.1023/a:1005956721457. View

5.
Hoffmann D, Adams J, Brunnemann K, RIVENSON A, Hecht S . Tobacco specific N-nitrosamines: occurrence and bioassays. IARC Sci Publ. 1982; (41):309-18. View